GSK’s drug combo shown to cut risk of death by 42% in type of blood cancer International News GSK’s drug combo shown to cut risk of death by 42% in type of blood cancer Admin December 10, 2024 December 9, 2024 British drugmaker GSK said on Monday its experimental cancer drug Blenrep in combination with...Read More
Admin 
